Skip to content

Celcuity CELC Net Change in Cash

Net Change in Cash at other companies

Eli Lilly logo
Eli LillyLLY
-$1.99B-1,035%
Gilead Sciences logo
Gilead SciencesGILD
$65M+103%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$309.88M+321%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$120.57M+492%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
-$70.8M-354%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$45.12M+507%

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.28B+1,370%
Enterprise value$4.27B+1,086%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Reported directly by Celcuity in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect.

The official record: Celcuity’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celcuity's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celcuity's net change in cash?
Celcuity (CELC) reported net change in cash of -$20.51M in Q1 2026.
How has Celcuity's net change in cash changed year-over-year?
Celcuity's net change in cash decreased by 239.8% year-over-year, from -$6.04M to -$20.51M.
What is the long-term trend for Celcuity's net change in cash?
Over 2 years (2021 to 2025), Celcuity's net change in cash has grown at a 34.9% compound annual growth rate (CAGR), from $78.73M to $143.19M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.